Evidence map›Paper›PMID 35532273›Full record

ArticleJournal of visualized experiments : JoVE2022

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis.

Hui-Lan Chang, Kang-Yi Su, Steven D Goodman, Wern-Cherng Cheng, Liang-In Lin, Ya-Chien Yang, Sui-Yuan Chang, Woei-Horng Fang

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hui-Lan Chang *Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University.
Kang-Yi Su *Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University; Department of Laboratory Medicine, National Taiwan University Hospital.
Steven D GoodmanCenter for Microbial Pathogenesis, Nationwide Children's Hospital and the Department of Pediatrics, The Ohio State University.
Wern-Cherng ChengDepartment of Laboratory Medicine, National Taiwan University Hospital.
Liang-In LinDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University; Department of Laboratory Medicine, National Taiwan University Hospital.
Ya-Chien YangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University; Department of Laboratory Medicine, National Taiwan University Hospital.
Sui-Yuan ChangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University; Department of Laboratory Medicine, National Taiwan University Hospital.
Woei-Horng FangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University; Department of Laboratory Medicine, National Taiwan University Hospital; whfang@ntu.edu.tw.
National Taiwan University · TWNational Taiwan University Hospital · TWThe Ohio State University · US

Funding

Novel immunotherapeutics for the management of otitis media due to H. influenzaeR01DC011818 · NIDCD · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BAKALETZ, LAUREN O, GOODMAN, STEVEN D · 2011 to 2020
$5.4M
NIDCD NIH HHS R01 DC011818
6 · The paper itself

Abstract

Uracil-DNA glycosylase (UDG) is a key component in the base excision repair pathway for the correction of uracil formed from hydrolytic deamination of cytosine. Thus, it is crucial for genome integrity maintenance. A highly specific, non-labeled, non-radio-isotopic method was developed to measure UDG activity. A synthetic DNA duplex containing a site-specific uracil was cleaved by UDG and then subjected to Matrix-assisted Laser Desorption/Ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis. A protocol was established to preserve the apurinic/apyrimidinic site (AP) product in DNA without strand break. The change in the m/z value from the substrate to the product was used to evaluate uracil hydrolysis by UDG. A G:U substrate was used for UDG kinetic analysis yielding the Km = 50 nM, Vmax = 0.98 nM/s, and Kcat = 9.31 s

Indexed as

DNA RepairUracil-DNA GlycosidaseDNAKineticsLasersSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationUracilDNAUracilUracil-DNA Glycosidase

Identifiers

PMID35532273
PMCPMC9505012
OpenAlexW4224224994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.